Premium
Ending cervical cancer: A call to action
Author(s) -
Aranda Sanchia,
Berkley Seth,
Cowal Sally,
Dybul Mark,
Evans Tim,
Iversen Katja,
Moeti Matshidiso,
Osotimehin Babatunde,
Peterson Stefan,
Piot Peter,
Purandare Chittaranjan N.,
Sidibé Michel,
Trimble Ted,
Tsu Vivien Davis
Publication year - 2017
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.12182
Subject(s) - cervical cancer , disadvantaged , medicine , disease , vaccination , action (physics) , human papillomavirus , call to action , incidence (geometry) , cancer , economic growth , demography , development economics , immunology , business , economics , sociology , advertising , physics , optics , quantum mechanics
The outlook for elimination of the scourge of cervical cancer is bright, because we now have the tools to achieve this goal. In recent years human papillomavirus (HPV) vaccination in high‐income countries has resulted in dramatic decreases in HPV infection and associated cervical disease. If all countries with a substantial burden of disease introduce the vaccine nationally, we can protect the vast majority of women and girls most at risk. For women who are beyond the vaccination target age, progress has been made in screening and treatment for cervical precancer, but we must accelerate this momentum to reduce incidence and mortality worldwide to the very low rates found in wealthier countries. Human and financial resources must be increased and directed to programs that follow best practices and reach all women, including the marginalized or disadvantaged. Seven key actions are recommended. Now is the time for action at national, regional, and global levels.